Clinical Trial: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07234942) titled 'A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)' on Nov. 14.

Brief Summary: This study aims to evaluate the safety, tolerability, immunogenicity, pharmacokinetics, and pharmacodynamics following administration of RO7812653 in participants with eAD.

Study Start Date: Jan. 31, 2026

Study Type: INTERVENTIONAL

Condition: Alzheimer's Disease

Intervention: DRUG: RO7812653

Participants will receive RO7812653 as per the schedule in the protocol

DRUG: Placebo

Participants will receive placebo as per the schedule in t...